Essex Bio-Technology
Overview
Essex Bio-Technology is a bio-pharmaceutical company that develops, manufactures, and commercializes genetically engineered therapeutic rb-bFGF (FGF-2). Its products are principally prescribed for wound healing and diseases in Ophthalmology and Dermatology. The company is publicly listed on the Hong Kong Stock Exchange and, through a subsidiary named Essex Bio-Investment, also makes strategic investments in other companies. The company's products are sold in approximately 14,100 hospitals in China.
Portfolio Companies
5
Website
essexbio.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| KroniKare | Oct 2020 | Series A | Co-investor |
| X-ZELL | Oct 2020 | Seed | Co-investor |
| Mitotech | Jul 2018 | Strategic | Lead |
| Antikor Biopharma | Jul 2019 | VC Round | Lead |
| YesDok | Jun 2019 | Convertible Debt | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Essex Bio-Technology based?
Essex Bio-Technology is headquartered in Hong Kong SAR.
When was Essex Bio-Technology founded?
Founding year information for Essex Bio-Technology is not publicly available.
How many portfolio companies does Essex Bio-Technology have?
Essex Bio-Technology has 5 portfolio companies in Caplight's dataset.
What are some companies in Essex Bio-Technology's portfolio?
Portfolio companies visible on Caplight include KroniKare, X-ZELL, Mitotech, Antikor Biopharma, YesDok.
What was Essex Bio-Technology's most recent investment shown here?
Essex Bio-Technology's most recent investment in this portfolio sample was in X-ZELL in 2020.
What sectors does Essex Bio-Technology focus on?
Essex Bio-Technology focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Essex Bio-Technology focus on?
Essex Bio-Technology typically invests at the MultiStage stage.